Is Synthetic Sciences profitable in 2026?

No revenue, ARR, or profit figures have been publicly disclosed for Synthetic Sciences as of July 2026. The company is a 2-person YC W26 graduate offering self-serve $50 and $200 monthly tiers, with no confirmed enterprise contracts or named paying customers reported by any third party.

Could AI replace Synthetic Sciences' product?

Yes, largely: Synthetic Sciences is an orchestration layer over Claude, GPT, GLM, Kimi and DeepSeek, not its own foundation model. Anthropic's Claude Science (beta, June 30, 2026), OpenAI's GPT-Rosalind (April 16, 2026), and Google's Gemini for Science (May 2026) now bundle equivalent workbenches free into existing subscriptions.

Who is Synthetic Sciences' biggest competitor?

Anthropic's Claude Science, launched in beta June 30, 2026 and bundled free into Claude Pro/Max/Team/Enterprise, with named customers Novo Nordisk and Allen Institute. Synthetic Sciences released its open-source OpenScience tool on July 4-5, 2026 explicitly positioned as a response to it.

Is Synthetic Sciences laying off staff?

There is no layoff activity to report: Synthetic Sciences is a 2-person founder team per Y Combinator's own company page (as of the W26 batch, early 2026), too small for layoffs, and no headcount reductions have been reported by any source.

Who owns Synthetic Sciences?

Synthetic Sciences is privately held and founder-owned, backed by Y Combinator as an accelerator investor through the Winter 2026 (W26) batch, per YC's own company page. No priced Seed or Series A round, valuation, or acquisition has been publicly reported as of July 2026.

Does Synthetic Sciences have any paying enterprise customers?

No named enterprise or pharma customers are confirmed by any third-party reporting as of July 14, 2026. The company markets self-serve $50 and $200 monthly tiers and is soliciting outreach to CTOs and Heads of R&D, suggesting it remains in early sales development rather than having closed enterprise deals.

YC Winter 2026 · United States

Synthetic Sciences

Two-person startup building a model-agnostic AI workbench for scientific research.

Protection under test

Assessed 27 July 2026 · Evidence as of 27 July 2026

Something worth protecting exists and is being tested right now.

On the recordSince 27 July 2026 · Checkable from Sept-Dec 2026 · Every call on the record Checkpoint: Anthropic's AI-for-Science grant awards (up to 50 projects) run Sept to Dec 2026, pulling researcher mindshare to Claude

The call

Three frontier labs shipped free science workbenches within ten weeks, leaving Synthetic Sciences to prove its on-prem, model-agnostic niche before the window closes.

Synthetic Sciences built software that sits on top of AI models like Claude and GPT to help scientists run experiments. The problem: Anthropic, OpenAI, and Google all released their own science tools for free in spring 2026, bundled into products millions already pay for, with major pharmaceutical companies already using them. Synthetic Sciences' only real advantage is that their tool works with multiple models at once and can run on a company's own computers for sensitive research, which matters for drug makers and governments worried about keeping secrets. The big test comes in the next six months: can they actually get pharmaceutical or government customers to pay for this, or will they stay with the free options from the giants?

Why

AI pressure: OpenAI GPT-Rosalind and Google Gemini for Science. Both launched science workbenches in 2026, folding the same workflow Synthetic Sciences sells into subscriptions people already pay for. Could AI do the core job? Yes, likely.

Bigger players: Anthropic (Claude Science). Claude Science launched free inside Claude Pro/Max/Team/Enterprise with Novo Nordisk and Allen Institute already signed as customers. Could a giant copy it? Yes, easily.

What protects it. Model-agnostic, on-premise deployment for regulated pharma and sovereign-AI buyers who cannot run everything on Claude alone.

What would change this call

Anthropic announces AI-for-Science grant awardees by Jul 31, 2026. Shows Claude Science locking in researcher mindshare during Synthetic Sciences' critical window.
OpenScience GitHub stars, forks, and contributor count over next 6 months. Flat or nominal growth would show the open-source wedge failed to gain traction.
A named pharma or sovereign-AI lab signs as a paying customer by Q4 2026. Would validate the compliance/on-prem wedge as a real business, not just a bundled feature.

Key numbers

2-person founding team (YC W26) (2026-02-26)
Claims 92% on BixBench Verified (vendor claim) (2026-02-26)
Claude Science launched free, bundled, June 30 (2026-06-30)

Named risks

Core value is a thin orchestration layer over frontier models now bundled free by Anthropic, OpenAI, Google. Severity: high
No priced funding round beyond an unconfirmed pre-seed reported; 2-person team facing well-capitalized rivals. Severity: high
Anthropic's grants program (up to 50 awards, Sept-Dec 2026) actively pulling target researchers toward Claude Science. Severity: medium
No named enterprise or pharma customer confirmed by third-party reporting as of July 2026. Severity: medium
Crowded open-source alternatives (Sakana AI, FutureHouse) already ahead in the free/open niche Synthetic Sciences is retreating to. Severity: medium

Rivals, as read in July 2026

Rival	Direction	Evidence
Anthropic (Claude Science)	losing to	Bundled free into subscriptions with Novo Nordisk, Allen Institute logos, June 30, 2026
OpenAI (GPT-Rosalind)	contesting	Enterprise preview shipped April 16, 2026, same niche
Google (Gemini for Science)	contesting	Launched at I/O May 2026 with 30+ life-science database integrations
Sakana AI (AI Scientist)	gaining on	Open-source, first AI-authored paper passed peer review, published Nature March 26, 2026
FutureHouse	gaining on	Nonprofit, free AI research agents since May 2025, ~15 staff, Eric Schmidt-backed

Questions people ask

Is Synthetic Sciences profitable in 2026?: No revenue, ARR, or profit figures have been publicly disclosed for Synthetic Sciences as of July 2026. The company is a 2-person YC W26 graduate offering self-serve $50 and $200 monthly tiers, with no confirmed enterprise contracts or named paying customers reported by any third party.
Could AI replace Synthetic Sciences' product?: Yes, largely: Synthetic Sciences is an orchestration layer over Claude, GPT, GLM, Kimi and DeepSeek, not its own foundation model. Anthropic's Claude Science (beta, June 30, 2026), OpenAI's GPT-Rosalind (April 16, 2026), and Google's Gemini for Science (May 2026) now bundle equivalent workbenches free into existing subscriptions.
Who is Synthetic Sciences' biggest competitor?: Anthropic's Claude Science, launched in beta June 30, 2026 and bundled free into Claude Pro/Max/Team/Enterprise, with named customers Novo Nordisk and Allen Institute. Synthetic Sciences released its open-source OpenScience tool on July 4-5, 2026 explicitly positioned as a response to it.
Is Synthetic Sciences laying off staff?: There is no layoff activity to report: Synthetic Sciences is a 2-person founder team per Y Combinator's own company page (as of the W26 batch, early 2026), too small for layoffs, and no headcount reductions have been reported by any source.
Who owns Synthetic Sciences?: Synthetic Sciences is privately held and founder-owned, backed by Y Combinator as an accelerator investor through the Winter 2026 (W26) batch, per YC's own company page. No priced Seed or Series A round, valuation, or acquisition has been publicly reported as of July 2026.
Does Synthetic Sciences have any paying enterprise customers?: No named enterprise or pharma customers are confirmed by any third-party reporting as of July 14, 2026. The company markets self-serve $50 and $200 monthly tiers and is soliciting outreach to CTOs and Heads of R&D, suggesting it remains in early sales development rather than having closed enterprise deals.

Timeline

2026-07-15Anthropic AI-for-Science grants program applications close, projects run Sept-Dec 2026
2026-07-05Synthetic Sciences releases OpenScience, open-source model-agnostic research workbench
2026-06-30Anthropic launches Claude Science beta with Novo Nordisk, Allen Institute as customers
2026-05-01Google launches Gemini for Science at I/O, covering 30+ life-science databases
2026-04-16OpenAI ships GPT-Rosalind in enterprise preview
2026-03-26Sakana AI's AI Scientist methodology published in Nature, first AI-authored paper to pass peer review
2026-02-26Synthetic Sciences launches publicly via YC W26 batch with 2-person team

Revision history

27 July 2026

First assessed. Protection under test. The text above is fixed as of this date and is not edited afterwards.

In the same band

Sequence Markets Piris Labs Inviscid AI